MAIA Biotechnology
MAIA | AMEX
$1.01
+$0.01 (+0.50%)
At close: Nov 16, 2026, 4:00 PM ET
$1.02
+$0.01 (+0.99%)
After-hours:
Nov 16, 2026, 7:20 PM ET
+0.50%
(1D)No price chart data available for 1D timeframe.
Rating
29.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #807/1021 (Top 79%)
Key Statistics
Market Data
Market Cap $62.37M
1D Range
0.96 1.05
52W Range
0.87 2.95
Valuation (TTM)
PE -2.10
PB 4.25
EV/EBITDA -1.66
Valuation (NTM)
Forward PE 1.03
Forward PEG 0.08
Price Target $0.00
Cash Flow
FCF Yield -40.7%
SBC Adj. FCF Yield -46.0%
SBC Impact -13.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 50.2% |
24.3%
FCF 3Y | 5Y -25.3% |
-21.1%
Returns
ROA -113.7%
ROE -153.4%
ROIC -176.7%
Financial Health
Net Cash
$21.34M
Current Ratio 3.41
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. ...
Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date Jul 28, 2022
Website www.MAIABiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MAIA